Why the study?
Does hydrochlorothiazide reduce plasma and extracellular fluid volumes in untreated patients with essential hypertension?
Does hydrochlorothiazide reduce plasma and extracellular fluid volumes in untreated patients with essential hypertension?
Long-term treatment with hydrochlorothiazide produces a sustained volume-depleting effect in patients with essential hypertension.
Answers are grounded in this paper and cite their sources.
Supports sustained volume reduction with hydrochlorothiazide in hypertension; extends mechanistic data but leaves open clinical impact in randomized trials.
In 13 untreated patients with essential hypertension, the plasma volume (T-1824) and the extracellular fluid volume ( 82 Br - distribution space) were determined three times. During treatment with 50 to 100 mg of hydrochlorothiazide daily, determinations of plasma volume and extracellular fluid volume were repeated after treatment for 1 mo (13 patients), 2 mo (13 patients), 4 mo (eight patients), and 6 mo ( seven patients). In all cases the average plasma and extracellular fluid volumes were reduced compared with the averages of three control values. The plasma volume was significantly reduced at the 5% level after treatment for 1, 2, and 4 mo. Corresponding studies from the literature have been reviewed and, on the basis of these studies and our own results, it is concluded that thiazides have a volume-depleting effect which is continued during long-term treatment of patients with essential hypertension.
No takes yet. Share an insight, caveat, or question.
Arne Leth (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: